Add Yahoo as a preferred source to see more of our stories on Google. Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial ...

Sponsors will now be able to submit preclinical toxicology data using virtual animal controls instead of a standard animal ...

Testing products on animals became an industry standard in the cosmetic, chemical, and pharmaceutical industries nearly a century ago. Since that time, it has become clear that these tests cause ...

Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug and chemical safety assessments. The FDA has released draft guidance ...

In a roadmap to change animal testing requirements for INDs, the U.S. FDA said its new approach will improve drug safety, hasten the evaluation process, and lower costs for companies and patients.

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Feinberg Professor emerita Eva Redei’s research had two key components: vats of water and “depressed” rats. Redei found that the rodents, genetically engineered in a Kyoto lab to exhibit depressive ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial intelligence, machine learning, digital twin, 5g, big data, iot ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Please provide your email address to receive an email when new articles are posted on . The U.S. has not seen the approval of a new sunscreen ingredient since the 1990s. The FDA’s plan to phase out ...